Oxidative stress in psoriasis and potential therapeutic use of antioxidants

References

• Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009;361:496–509.
   PubMed Web of Science ®Google Scholar
• Johnson-Huang LM, Lowes MA, Krueger JG. Putting together the psoriasis puzzle: an update on developing targeted therapies. Dis Model Mech 2012;5:423–433.
   PubMed Web of Science ®Google Scholar
• Kadam DP, Suryakar AN, Ankush RD, Kadam CY, Deshpande KH. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem 2010;25:388–392.
   PubMedGoogle Scholar
• Mansouri Y, Goldenberg G. New systemic therapies for psoriasis. Cutis 2015;95:155–160.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 2009;47:891–905.
   PubMed Web of Science ®Google Scholar
• Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 2004;251:261–268.
   PubMed Web of Science ®Google Scholar
• Sheremata W, Brown AD, Rammohan KW. Dimethyl fumarate for treating relapsing multiple sclerosis. Expert Opin Drug Saf 2015;14:161–170.
   PubMed Web of Science ®Google Scholar
• Yazdi MR, Mrowietz U. Fumaric acid esters. Clin Dermatol 2008;26:522–526.
   PubMed Web of Science ®Google Scholar
• Ogura S, Shimosawa T. Oxidative stress and organ damages. Curr Hypertens Rep 2014;16:452–456.
   PubMed Web of Science ®Google Scholar
• Reczek CR, Chandel NS. ROS-dependent signal transduction. Curr Opin Cell Biol 2015;33:8–13.
   PubMed Web of Science ®Google Scholar
• Harrison DG. Basic science: pathophysiology: oxidative stress. J Am Soc Hypertens 2014;8:601–603.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol 2015;4:180–183.
   PubMed Web of Science ®Google Scholar
• Poljsak B, Šuput D, Milisav I. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxid Med Cell Longev 2013;2013:956792.
   PubMed Web of Science ®Google Scholar
• Havens CG, Ho A, Yoshioka N, Dowdy SF. Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species. Mol Cell Biol 2006;26:4701–4711.
   PubMed Web of Science ®Google Scholar
• Halliwell B . Oxidative stress and cancer: have we moved forward? Biochem J 2007;401:1–11
   PubMed Web of Science ®Google Scholar
• Han Y, Huang C, Sun X, Xiang B, Wang M, Yeh ET, et al. SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J Biol Chem 2010;285:12906–12915.
   PubMed Web of Science ®Google Scholar
• Lei Y, Wang K, Deng L, Chen Y, Nice EC, Huang C. Redox regulation of inflammation: old elements, a new story. Med Res Rev 2015;35:306–340.
   PubMed Web of Science ®Google Scholar
• Wagener FA, Carels CE, Lundvig DM. Targeting the redox balance in inflammatory skin conditions. Int J Mol Sci 2013;14:9126–9167.
   PubMed Web of Science ®Google Scholar
• Nemati H, Khodarahmi R, Sadeghi M, Ebrahimi A, Rezaei M, Vaisi-Raygani A. Antioxidant status in patients with psoriasis. Cell Biochem Funct 2014;32:268–273.
   PubMed Web of Science ®Google Scholar
• Barygina VV, Becatti M, Soldi G, Prignano F, Lotti T, Nassi P, et al. Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Rep 2013;18:100–106.
   PubMed Web of Science ®Google Scholar
• Pujari VM, Ireddy S, Itagi I, Kumar H S. The serum levels of malondialdehyde, vitamin E and erythrocyte catalase activity in psoriasis patients. J Clin Diagn Res 2014;8:CC14–CC16.
   Google Scholar
• Drewa G, Krzyzyńska-Malinowska E, Woźniak A, Protas-Drozd F, Mila-Kierzenkowska C, Rozwodowska M, et al. Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis. Med Sci Monit 2002: 8:BR338–BR343.
   Google Scholar
• Relhan V, Gupta SK, Dayal S, Pandey R, Lal H. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol 2002;29:399–403.
   PubMed Web of Science ®Google Scholar
• Baz K, Cimen MY, Kokturk A, Yazici AC, Eskandari G, Ikizoglu G, et al . Oxidant/antioxidant status in patients with psoriasis. Yonsei Med J 2003;44:987–990.
   PubMed Web of Science ®Google Scholar
• Gabr SA, Al-Ghadir AH. Role of cellular oxidative stress and cytochrome C in the pathogenesis of psoriasis. Arch Dermatol Res 2012;304:451–457.
   PubMed Web of Science ®Google Scholar
• Sikar Aktürk A, Özdoğan HK, Bayramgürler D, Çekmen MB, Bilen N, Kıran R. Nitric oxide and malondialdehyde levels in plasma and tissue of psoriasis patients. J Eur Acad Dermatol Venereol 2012;26:833–837
   PubMed Web of Science ®Google Scholar
• Ferretti G, Bacchetti T, Campanati A, Simonetti O, Liberati G, Offidani A. Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1. Br J Dermatol 2012;166:204–207.
   PubMed Web of Science ®Google Scholar
• Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001;303:33–39.
   PubMed Web of Science ®Google Scholar
• Woźniak A, Drewa G, Krzyzyńska-Maliniowska E, Czajkowski R, Protas-Drozd F, Mila-Kierzenkowska C, et al. Oxidant-antioxidant balance in patients with psoriasis. Med Sci Monit 2007;13:CR30–CR33.
   PubMed Web of Science ®Google Scholar
• Yildirim M, Inaloz HS, Baysal V, Delibas N. The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venereol 2003;17:34–36.
   PubMed Web of Science ®Google Scholar
• Hashemi M, Mehrabifar H, Daliri M, Ghavami S. Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis. J Eur Acad Dermatol Venereol 2010;24:329–334.
   PubMed Web of Science ®Google Scholar
• Karababa F, Yesilova Y, Turan E, Selek S, Altun H, Selek S. Impact of depressive symptoms on oxidative stress in patients with psoriasis. Redox Rep 2013;18:51–55.
   PubMed Web of Science ®Google Scholar
• Sürücü HA, Aksoy N, Ozgöztas O, Sezen H, Yesilova Y, Turan E. Prolidase activity in chronic plaque psoriasis patients. Postepy Dermatol Alergol 2015;32:82–87.
   PubMed Web of Science ®Google Scholar
• Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 2009;129:79–88.
   PubMed Web of Science ®Google Scholar
• Kim J, Krueger JG. The immunopathogenesis of psoriasis. Dermatol Clin 2015;33:13–23.
   PubMed Web of Science ®Google Scholar
• Perera GK, Di Meglio P, Nestle FO. Psoriasis. Annu Rev Pathol 2012;7:385–422.
   PubMed Web of Science ®Google Scholar
• Johnson-Huang LM, McNutt NS, Krueger JG, Lowes MA. Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases. J Clin Immunol 2009;29:247–256.
   PubMed Web of Science ®Google Scholar
• Sheng KC, Pietersz GA, Tang CK, Ramsland PA, Apostolopoulos V. Reactive oxygen species level defines two functionally distinctive stages of inflammatory dendritic cell development from mouse bone marrow. J Immunol 2010;184:2863–2872.
   PubMed Web of Science ®Google Scholar
• Verhasselt V, Goldman M, Willems F. Oxidative stress up-regulates IL-8 and TNF-alpha synthesis by human dendritic cells. Eur J Immunol 1998;28:3886–3890.
   PubMed Web of Science ®Google Scholar
• Rutault K, Alderman C, Chain BM, Katz DR. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med 1999;26:232–238.
   PubMed Web of Science ®Google Scholar
• Kantengwa S, Jornot L, Devenoges C, Nicod LP. Superoxide anions induce the maturation of human dendritic cells. Am J Respir Crit Care Med 2003;167:431–437.
   PubMed Web of Science ®Google Scholar
• Batal I, Azzi J, Mounayar M, Abdoli R, Moore R, Lee JY, et al. The mechanisms of up-regulation of dendritic cell activity by oxidative stress. J Leukoc Biol 2014;96:283–293.
   PubMed Web of Science ®Google Scholar
• Kyriakou A, Patsatsi A, Vyzantiadis TA, Sotiriadis D. Serum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity. J Immunol Res 2014;2014:467541.
   PubMed Web of Science ®Google Scholar
• Cai Y, Fleming C, Yan J. New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol 2012;9:302–309.
   PubMed Web of Science ®Google Scholar
• Simeoni L, Bogeski I. Redox regulation of T-cell receptor signaling. Biol Chem 2015;396:555–568.
   PubMed Web of Science ®Google Scholar
• Jain S, Kaur IR, Das S, Bhattacharya SN, Singh A. T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression? J Med Microbiol 2009;58:180–184.
   PubMed Web of Science ®Google Scholar
• Nograles KE, Davidovici B, Krueger JG. New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg 2010;29:3–9.
   PubMed Web of Science ®Google Scholar
• Gostner JM, Becker K, Fuchs D, Sucher R. Redox regulation of the immune response. Redox Rep 2013;18:88–94.
   PubMed Web of Science ®Google Scholar
• Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol 2014;32:227–255.
   PubMed Web of Science ®Google Scholar
• Bito T, Nishigori C. Impact of reactive oxygen species on keratinocyte signaling pathways. J Dermatol Sci 2012;68:3–8.
   PubMed Web of Science ®Google Scholar
• Brotas AM, Cunha JM, Lago EH, Machado CC, Carneiro SC. Tumor necrosis factor-alpha and the cytokine network in psoriasis. An Bras Dermatol 2012;87:673–681.
   PubMed Web of Science ®Google Scholar
• Young CN, Koepke JI, Terlecky LJ, Borkin MS, Boyd Savoy L, Terlecky SR. Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol 2008;128:2606–2614.
   PubMed Web of Science ®Google Scholar
• Weidemann AK, Crawshaw AA, Byrne E, Young HS. Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin Cosmet Investig Dermatol 2013;6:233–244.
   PubMedGoogle Scholar
• Heidenreich R, Röcken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol 2009;90:232–248.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci 2011;63:1–9.
   PubMed Web of Science ®Google Scholar
• Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 2002;277:3101–3108.
   PubMed Web of Science ®Google Scholar
• West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010;467:972–976.
   PubMed Web of Science ®Google Scholar
• Kim YW, Byzova TV. Oxidative stress in angiogenesis and vascular disease. Blood 2014;123:625–631.
   PubMed Web of Science ®Google Scholar
• Son Y, Kim S, Chung HT, Pae HO. Reactive oxygen species in the activation of MAP kinases. Meth Enzymol 2013;528:27–48.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Ibe M, Nakamura S, Ishida-Yamamoto A, Hashimoto Y, Iizuka H. Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci 2002;30:94–99.
   PubMed Web of Science ®Google Scholar
• Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol 2005;152:37–42.
   PubMed Web of Science ®Google Scholar
• Yu XJ, Li CY, Dai HY, Cai DX, Wang KY, Xu YH, et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol 2007;83:413–418.
   PubMed Web of Science ®Google Scholar
• Wang S, Uchi H, Hayashida S, Urabe K, Moroi Y, Furue M. Differential expression of phosphorylated extracellular signal-regulated kinase 1/2, phosphorylated p38 mitogen-activated protein kinase and nuclear factor-kappaB p105/p50 in chronic inflammatory skin diseases. J Dermatol 2009;36:534–540.
   PubMed Web of Science ®Google Scholar
• Mihara K, Elliott GR, Boots AM, Nelissen RL. Inhibition of p38 kinase suppresses the development of psoriasis-like lesions in a human skin transplant model of psoriasis. Br J Dermatol 2012;167:455–457.
   PubMed Web of Science ®Google Scholar
• Soegaard-Madsen L, Johansen C, Iversen L, Kragballe K. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement. Br J Dermatol 2010;162:1216–1223.
   PubMed Web of Science ®Google Scholar
• Moorchung N, Kulaar JS, Chatterjee M, Vasudevan B, Tripathi T, Dutta V. Role of NF-κB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens. Int J Dermatol 2014;53:570–574.
   PubMed Web of Science ®Google Scholar
• Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF. NF-κB: an essential transcription factor in psoriasis. J Dermatol Sci 2013;69:89–94.
   PubMed Web of Science ®Google Scholar
• Nakajima S, Kitamura M. Bidirectional regulation of NF-κB by reactive oxygen species: a role of unfolded protein response. Free Radic Biol Med 2013;65:162–174.
   PubMed Web of Science ®Google Scholar
• Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 2011;21:103–115.
   PubMed Web of Science ®Google Scholar
• Aittomäki S, Pesu M. Therapeutic targeting of the Jak/STAT pathway. Basic Clin Pharmacol Toxicol 2014;114:18–23.
   PubMed Web of Science ®Google Scholar
• Hsu L, Armstrong AW. JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis. J Immunol Res 2014;2014:283617.
   PubMed Web of Science ®Google Scholar
• Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005;11:43–49.
   PubMed Web of Science ®Google Scholar
• Hald A, Andrés RM, Salskov-Iversen ML, Kjellerup RB, Iversen L, Johansen C. STAT1 expression and activation is increased in lesional psoriatic skin. Br J Dermatol 2013;168:302–310.
   PubMed Web of Science ®Google Scholar
• Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 1998;275:C1640–C1652.
   PubMed Web of Science ®Google Scholar
• Carballo M, Conde M, Bekay RE, Nieto JM, Camacho MJ, Monteseirin J, et al. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem 1999;274:17580–17586.
   PubMed Web of Science ®Google Scholar
• Madamanchi NR, Li S, Patterson C, Runge MS. Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler Thromb Vasc Biol 2001;21:321–326.
   PubMed Web of Science ®Google Scholar
• Bast A, Haenen GR. Ten misconceptions about antioxidants. Trends Pharmacol Sci 2013;34:430–436.
   PubMed Web of Science ®Google Scholar
• Niki E. Antioxidants: basic principles, emerging concepts, and problems. Biomed J 2014;37:106–111.
   PubMedGoogle Scholar
• Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009;23:1–70.
   PubMed Web of Science ®Google Scholar
• Onderdijk AJ, Balak DM, Baerveldt EM, Florencia EF, Kant M, Laman JD, et al. Regulated genes in psoriatic skin during treatment with fumaric acid esters. Br J Dermatol 2014;171:732–741.
   PubMed Web of Science ®Google Scholar
• Bovenschen HJ, Langewouters AM, van de Kerkhof PC. Dimethylfumarate for psoriasis: pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study. Am J Clin Dermatol 2010;11:343–350.
   PubMed Web of Science ®Google Scholar
• Fox RJ, Kita M, Cohan SL, Henson LJ, Zambrano J, Scannevin RH, et al. BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety. Curr Med Res Opin 2014;30:251–262.
   PubMed Web of Science ®Google Scholar
• Roll A, Reich K, Boer A. Use of fumaric acid esters in psoriasis. Indian J Dermatol Venereol Leprol 2007;73:133–137.
   PubMed Web of Science ®Google Scholar
• El-Bassossy HM, Watson ML. Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system. J Transl Med 2015;13:82–92.
   PubMed Web of Science ®Google Scholar
• George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006; 114: 2508–2516.
   PubMed Web of Science ®Google Scholar
• Namazi MR. Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunition. J Eur Acad Dermatol Venereol 2005;19:319–322.
   PubMed Web of Science ®Google Scholar
• Tsai TF, Yeh TY. Allopurinol in dermatology. Am J Clin Dermatol 2010;11:225–232.
   PubMed Web of Science ®Google Scholar
• Utaş S, Köse K, Yazici C, Akdaş A, Keleştimur F. Antioxidant potential of propylthiouracil in patients with psoriasis. Clin Biochem 2002;35:241–246.
   PubMed Web of Science ®Google Scholar
• Elias AN, Goodman MM, Liem WH, Barr RJ. Propylthiouracil in psoriasis: results of an open trial. J Am Acad Dermatol 1993;29:78–81.
   PubMed Web of Science ®Google Scholar
• Elias AN, Dangaran K, Barr RJ, Rohan MK, Goodman MM. A controlled trial of topical propylthiouracil in the treatment of patients with psoriasis. J Am Acad Dermatol 1994;31:455–458.
   PubMed Web of Science ®Google Scholar
• Gnanaraj P, Dayalan H, Elango T, Malligarjunan H, Raghavan V, Rao R. Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis. Int J Dermatol 2015;54:302–306.
   PubMed Web of Science ®Google Scholar
• Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008;65:1631–1652.
   PubMed Web of Science ®Google Scholar
• Kurd SK, Smith N, VanVoorhees A, Troxel AB, Badmaev V, Seykora JT, et al. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. J Am Acad Dermatol 2008;58:625–631.
   PubMed Web of Science ®Google Scholar
• Antiga E, Bonciolini V, Volpi W, Del Bianco E, Caproni M. Oral curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce il-22 serum levels in patients with Psoriasis vulgaris. Biomed Res Int 2015;2015:283634.
   PubMed Web of Science ®Google Scholar
• Jowkar F, Namazi MR . Statins in dermatology. Int J Dermatol 2010;49:1235–1243.
   PubMed Web of Science ®Google Scholar
• Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition 2010;26:250–254.
   PubMed Web of Science ®Google Scholar
• Niki E. Evidence for beneficial effects of vitamin E. Korean J Intern Med 2015;30:571–579.
   PubMed Web of Science ®Google Scholar
• Roman M, Jitaru P, Barbante C. Selenium biochemistry and its role for human health. Metallomics 2014;6:25–54.
   PubMed Web of Science ®Google Scholar
• Kharaeva Z, Gostova E, De Luca C, Raskovic D, Korkina L. Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition 2009;25:295–302.
   PubMed Web of Science ®Google Scholar
• Hu CC, Lin JT, Lu FJ, Chou FP, Yang DJ. Determination of carotenoids in Dunaliella salina cultivated in Taiwan and antioxidant capacity of the algal carotenoid extract. Food Chem 2008;109:439–446.
   PubMed Web of Science ®Google Scholar
• Greenberger S, Harats D, Salameh F, Lubish T, Harari A, Trau H, et al. 9-cis-rich b-carotene powder of the alga Dunaliella reduces the severity of chronic plaque psoriasis: a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Nutr 2012;31:320–326.
   PubMed Web of Science ®Google Scholar
• Prussick R, Prussick L, Gutman J. Psoriasis improvement in patients using glutathione-enhancing, nondenatured whey protein isolate: a pilot study. J Clin Aesthet Dermatol 2013;6:23–26.
   PubMedGoogle Scholar
• Yang R, Zhou Q, Wen C, Hu J, Li H, Zhao M, Zhao H. Mustard seed (Sinapis Alba Linn) attenuates imiquimod-induced psoriasiform inflammation of BALB/c mice. J Dermatol 2013;40:543–552.
   PubMed Web of Science ®Google Scholar